What is the latest ZIMLAB stock price?
The latest stored price for ZIMLAB is Rs 135.51 as of 2026-09-18.
gimli
ZIMLAB stock AI analysis
ZIMLAB Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
ZIM LABORATORIES LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available ZIMLAB price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹135.51
1W return
-0.67%
1M return
+18.34%
3M return
+18.90%
6M return
+101.08%
1Y return
+80.37%
Market cap
₹725.64 cr
PE
188.97
PB
2.45
ROE
+1.40%
ROCE
+5.19%
RSI
59.60
Turnover
₹1.73 cr
Why it can matter in screens
- Momentum: ZIMLAB is above 50DMA, above 200DMA; RSI is 59.60.
- Returns: 1D -1.75%, 1W -0.67%, 1M +18.34%, 3M +18.90%, 1Y +80.37%.
- Trend levels: 52W high ₹144.49, 52W low ₹99.06, off high -6.21%.
- Liquidity: latest turnover is ₹1.73 cr; volume vs 20D is +0.87%.
- Valuation/profitability: PE 188.97, PB 2.45, ROE +1.40%, ROCE +5.19%.
- Growth: 3Y sales CAGR -2.52%, 3Y profit CAGR -37.93%.
Quick Answers
Is ZIMLAB above its 50DMA and 200DMA?
ZIMLAB is above 50DMA, above 200DMA. The latest 50DMA is 120.93 and the latest 200DMA is 92.99.
What are ZIMLAB PE, ROE and ROCE?
ZIMLAB has PE 188.97, ROE +1.40%, and ROCE +5.19% in Gimli's latest available snapshot.
How has ZIMLAB performed recently?
ZIMLAB has returned +18.34% over 1 month, +18.90% over 3 months, and +80.37% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 94.04 cr | 3.39 cr | -3.88 cr | -0.72 |
| 2026-03-31 | 105.27 cr | 13.35 cr | 3.74 cr | 0.76 |
| 2025-12-31 | 108.66 cr | 14.51 cr | 4.40 cr | 0.90 |
| 2025-09-30 | 88.71 cr | 7.80 cr | -0.42 cr | -0.09 |
| 2025-06-30 | 71.76 cr | 5.74 cr | -1.87 cr | -0.38 |
| 2025-03-31 | 108.73 cr | 16.31 cr | 4.88 cr | 1.01 |
| 2024-12-31 | 96.33 cr | 13.32 cr | 4.00 cr | 0.82 |
| 2024-09-30 | 92.14 cr | 10.85 cr | n/a | 0.49 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 360.04 cr | 40.27 cr | 5.84 cr | 1.22 |
| 2025-03-31 | 362.89 cr | 48.37 cr | 12.17 cr | 2.50 |
| 2024-03-31 | 355.51 cr | 45.48 cr | 17.25 cr | 3.54 |
| 2023-03-31 | 388.73 cr | 57.79 cr | 24.43 cr | 5.01 |
| 2022-03-31 | 334.00 cr | 44.24 cr | 13.01 cr | 2.99 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 539.39 cr | 25.12 cr | 126.40 cr | 296.15 cr |
| 2025-03-31 | 472.27 cr | 1.95 cr | 117.68 cr | 252.24 cr |
| 2024-03-31 | 446.82 cr | 9.60 cr | 111.63 cr | 238.75 cr |
| 2023-03-31 | 341.58 cr | 6.42 cr | 62.00 cr | 200.35 cr |
| 2022-03-31 | 341.63 cr | 3.42 cr | 53.32 cr | 175.71 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 49.53 cr | 5.15 cr | n/a |
| 2025-03-31 | 41.15 cr | 0.36 cr | n/a |
| 2024-03-31 | 16.28 cr | -57.65 cr | n/a |
| 2023-03-31 | 38.17 cr | 1.50 cr | n/a |
| 2022-03-31 | 49.21 cr | 33.98 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +30.36% | +0.03% | +1.33% | +1.07% | +68.28% | +0.00% |
| 2026-03-31 | +30.35% | +0.00% | +0.07% | +0.00% | +69.58% | +0.00% |
| 2026-03-13 | +30.30% | +0.00% | +0.07% | +0.00% | +69.63% | +0.00% |
| 2025-12-31 | +33.26% | +0.02% | +0.20% | +0.00% | +66.52% | +0.00% |
| 2025-09-30 | +33.26% | +0.00% | +0.24% | +0.00% | +66.51% | +0.00% |
| 2025-06-30 | +33.26% | +0.03% | +0.24% | +0.00% | +66.46% | +0.00% |
| 2025-03-31 | +33.26% | +0.01% | +0.24% | +0.00% | +66.49% | +0.00% |
| 2024-12-31 | +33.26% | +0.21% | +0.24% | +0.00% | +66.28% | +0.00% |
| 2024-09-30 | +33.26% | +0.00% | +0.10% | +0.00% | +66.63% | +0.00% |
| 2024-06-30 | +33.26% | +0.00% | +0.11% | +0.00% | +66.63% | +0.00% |
| 2024-03-31 | +33.26% | +0.01% | +0.00% | +0.00% | +66.73% | +0.00% |
| 2023-12-31 | +33.26% | +0.00% | +0.00% | +0.00% | +66.74% | +0.00% |
| 2023-09-30 | +33.26% | +0.00% | +0.00% | +0.00% | +66.74% | +0.00% |
| 2023-06-30 | +33.26% | +0.06% | +0.00% | +0.00% | +66.68% | +0.00% |
| 2023-03-31 | +33.26% | +0.00% | +0.00% | +0.00% | +66.74% | +0.00% |
| 2022-12-31 | +33.26% | +0.00% | +0.00% | +0.00% | +66.74% | +0.00% |
| 2022-12-23 | +33.26% | +0.00% | +0.00% | +0.00% | +66.74% | +0.00% |
| 2022-09-30 | +33.26% | +0.00% | +0.00% | +0.00% | +66.74% | n/a |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 440,829.82 cr | 36.388220 | +15.50% | +11.45% |
| DIVISLAB | DIVI S LABORATORIES LTD | 248,876.81 cr | 85.407280 | +18.37% | +53.39% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 163,807.57 cr | 75.106636 | +17.33% | +35.67% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,608.22 cr | 65.670049 | +21.03% | +13.94% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 116,723.14 cr | 26.011308 | +16.04% | +10.70% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 33.401961 | +10.25% | -11.64% |
| LAURUSLABS | LAURUS LABS LIMITED | 105,487.98 cr | 96.587446 | +21.77% | +111.64% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 102,122.47 cr | 70.799892 | +14.33% | -10.58% |
Try these prompts
- Analyze ZIM LABORATORIES with valuation, momentum and industry peers
- Compare ZIMLAB with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ZIMLAB with other Healthcare stocks
Data snapshot: 2026-09-18. Not investment advice.